STSS stock news

Sharps Technology (NASDAQ: STSS) stock plummeted during pre-market trading Friday despite securing a lucrative 5-year, $200 million syringe sales deal […]

Sharps Technology (NASDAQ: STSS) stock skyrocketed during intraday trading Tuesday after the company secured exclusive syringe manufacturing agreements with Nephron